Getting a Handle of Hidradenitis Suppurativa Through Holistic Management: An Online Activity

This 20-minute Seminar in Depth from the 2025 Winter Clinical Miami and Hawaii conferences features a discussion of the pharmacologic and non-pharmacologic management of hidradenitis suppurativa, including clinical data for new/emerging therapies.

“When they (patients) have declared that they're getting recurrent nodules and abscesses, HS has declared that it's going to be an active part of their life... Certainly, if they're a Hurley stage II and have already started to develop tunnel formation, I am recommending that patients start a systemic, either a biologic or (soon) small molecule therapy.” – Dr. Tiffany Mayo

This activity is supported by educational grants from Incyte, Novartis Pharmaceuticals Corporation, and UCB, Inc.